This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Dec 22;314(5807):1859-60.

doi: 10.1126/science.314.5807.1859a.

Immunology. Mouse studies question importance of toll-like receptors to vaccines

Ingrid Wickelgren

PMID: 17185572
DOI: 10.1126/science.314.5807.1859a

Comment

Immunology. Mouse studies question importance of toll-like receptors to vaccines

Ingrid Wickelgren. Science. 2006.

. 2006 Dec 22;314(5807):1859-60.

doi: 10.1126/science.314.5807.1859a.

Author

Ingrid Wickelgren

PMID: 17185572
DOI: 10.1126/science.314.5807.1859a

No abstract available

PubMed Disclaimer

Comment on

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.
Gavin AL, Hoebe K, Duong B, Ota T, Martin C, Beutler B, Nemazee D. Gavin AL, et al. Science. 2006 Dec 22;314(5807):1936-8. doi: 10.1126/science.1135299. Science. 2006. PMID: 17185603 Free PMC article.

Similar articles

Toll-free vaccines?
Krieg AM. Krieg AM. Nat Biotechnol. 2007 Mar;25(3):303-5. doi: 10.1038/nbt0307-303. Nat Biotechnol. 2007. PMID: 17344883 No abstract available.
Tolls and beyond--many roads to vaccine immunity.
Pulendran B. Pulendran B. N Engl J Med. 2007 Apr 26;356(17):1776-8. doi: 10.1056/NEJMcibr070454. N Engl J Med. 2007. PMID: 17460233 No abstract available.
Toll-like receptors and innate immunity in B-cell activation and antibody responses.
Lanzavecchia A, Sallusto F. Lanzavecchia A, et al. Curr Opin Immunol. 2007 Jun;19(3):268-74. doi: 10.1016/j.coi.2007.04.002. Epub 2007 Apr 12. Curr Opin Immunol. 2007. PMID: 17433875 Review.
Taking a toll road to better vaccines.
Morley SC, Allen PM. Morley SC, et al. Immunity. 2008 May;28(5):602-4. doi: 10.1016/j.immuni.2008.04.008. Immunity. 2008. PMID: 18482564
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists.
Kanzler H, Barrat FJ, Hessel EM, Coffman RL. Kanzler H, et al. Nat Med. 2007 May;13(5):552-9. doi: 10.1038/nm1589. Nat Med. 2007. PMID: 17479101 Review.

See all similar articles

Cited by

Vaccine-induced antibody isotypes are skewed by impaired CD4 T cell and invariant NKT cell effector responses in MyD88-deficient mice.
Iweala OI, Smith DW, Matharu KS, Sada-Ovalle I, Nguyen DD, Dekruyff RH, Umetsu DT, Behar SM, Nagler CR. Iweala OI, et al. J Immunol. 2009 Aug 15;183(4):2252-60. doi: 10.4049/jimmunol.0804011. Epub 2009 Jul 20. J Immunol. 2009. PMID: 19620295 Free PMC article.
Toll-like receptors and leishmaniasis.
Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V. Tuon FF, et al. Infect Immun. 2008 Mar;76(3):866-72. doi: 10.1128/IAI.01090-07. Epub 2007 Dec 10. Infect Immun. 2008. PMID: 18070909 Free PMC article. Review. No abstract available.
MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen.
Park SM, Ko HJ, Shim DH, Yang JY, Park YH, Curtiss R 3rd, Kweon MN. Park SM, et al. J Immunol. 2008 Nov 1;181(9):6447-55. doi: 10.4049/jimmunol.181.9.6447. J Immunol. 2008. PMID: 18941235 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
Medical
- MedlinePlus Health Information